AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has ...

The fight to lower prescription drug prices is hitting African Americans especially hard. A recent report by Patients ...

A recent report by Patients for Affordable Drugs reveals that pharmaceutical companies have increased prices on more than ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

NICE and drugmakers AstraZeneca and Daiichi Sankyo have all expressed their disappointment at being unable to agree on a price for Enhertu that would allow it to be used on the NHS for people with ...

Jefferies analyst Peter Welford maintained a Hold rating on AstraZeneca (AZN – Research Report) today and set a price target of £114.00.

Bank of America Securities analyst Sachin Jain has reiterated their bullish stance on AZN stock, giving a Buy rating on September 30. Sachin ...

Prime Minister Netanyahu warned Iran of severe consequences for its missile attacks on Israel, emphasizing Israel's determination to retaliate decisively. Information ...

Prime Minister Benjamin Netanyahu said Israel would retaliate against Iran after Tuesday’s missile attack. President Biden said he supported Israel’s right to defend itself but urged it not to ...

CNN anchor Jim Acosta cut short an interview with Corey Lewandowski after he repeatedly mispronounced Vice President Kamala Harris’ name despite being corrected. The discussion grew heated over ...

Donald Trump’s campaign reported raising over $160 million in September as it gears up for the final five weeks of the presidential election. Trump’s official campaign, joint fundraising ...

After Missile Attack, Israel May Be Ready to Risk All-Out War With Iran Israel seems ready to respond in a much more forceful, public way after Tehran launched its second massive missile attack on ...